Swiss stocks – Factors to watch on Dec 23

ZURICH, Dec 23 (BestGrowthStock) – Swiss equities were expected to
open higher on Thursday, with shares across Europe extending
their brisk Christmas rally and buoyant oil prices lending
support to heavyweight energy shares.

The Swiss blue-chip index (.SSMI: ) was seen opening up 9
points at 6,566 points, pre-market data provided by bank
Clariden Leu (CLPRE: ) showed.

The following are some of the main factors expected to
affect Swiss stocks:


A former UBS banker pleaded guilty on Wednesday to charges
he helped wealthy American clients hide their money from U.S.
tax authorities as American officials stepped up a crackdown on
offshore tax evasion.

For related news, click on [UBSN.VX]


* Novartis said it has submitted an application to the
European Medicines Agency (EMA) for Bexsero, in the hopes it
will become the first broad-coverage vaccine licensed for use
against disease caused by meningococcal serogroup B bacteria in
the European Union.

* Novartis said late on Wednesday it had gained FDA approval
for Amturnide(TM), a triple-combination pill to treat high blood
pressure in patients uncontrolled on two medications.

For related news, click on [NOVN.VX]



* Schindler (SCHN.S: ) and Compania de Servicios S.A. said
they plan a share purchase agreement and later intended merger in

* Partners Group (PGHN.S: ) said it had invested in satellite
communication services provider Vizada on behalf of its clients.
* Axpo, Alpiq (ALPH.S: ) and BKW (BKWN.S: ) have agreed to join
forces in further pursuing the planning and construction of two
new nuclear power stations to replace nuclear power generating
facilities in Switzerland.


For companies trading ex-dividend, please click on:

(.EX.S: ) for all swiss stocks

(.EXSMI.S: ) for blue chips

(.EXNSMI.S: ) for other stocks

Swiss stocks – Factors to watch on Dec 23